RESEARCH PROGRESS ON FUNCTION, ABSORPTION AND METABOLISM OF VITAMIN K
WANG Hai-yan, NIE Shu-hui, HU Yi-chun, YANG Xiao-guang
Author information+
Nutritional Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Key Laboratory of Trace Element and Nutrition of the Health Commission, Beijing 100050,China
In recent years, the different types of vitamin K have shown potential health effects on prevention and treatment of osteoporosis, improvement of cardiovascular disease, prevention of diabetes and some types of cancer, in addition to coagulation function. In this review, the physiological function of vitamin K, and the similarities and differences between vitamin K1 and vitamin K2 in terms of their absorption, transport, storage and excretion in the human body are discussed. The effects of different types of vitamin K, dietary composition and gene polymorphism (APOE, VKOR, CYP4F2, etc.) on vitamin K metabolism were also outlined to provide a reference for future study and the development of dietary reference intakes.
WANG Hai-yan, NIE Shu-hui, HU Yi-chun, YANG Xiao-guang.
RESEARCH PROGRESS ON FUNCTION, ABSORPTION AND METABOLISM OF VITAMIN K[J]. Acta Nutrimenta Sinica. 2025, 47(1): 92-98
中图分类号：
R151
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Dam H.The antihmorrhagic vitamin of the chick: occurrence and chemical nature[J]. Nature,1935,135: 652–653.
[2] Shea MK, Booth SL.Concepts and controversies in evaluating vitamin K status in population-based studies[J].Nutrients, 2016, 8: 8.
[3] Schurgers LJ, Vermeer C.Determination of phylloquinone and menaquinones in food[J].Haemostasis, 2000, 30: 298–307.
[4] Halder M, Petsophonsakul P, Akbulut AC, et al. Vitamin K: double bonds beyond coagulation insights into differences between vitamin K1 and K2 in health and disease[J]. Int J Mol Sci, 2019, 20: 896–896.
[5] Walther B, Karl JP, Booth SL, et al. Menaquinones, bacteria, and the food supply: the relevance of dairy and fermented food products to vitamin K requirements[J]. Adv Nutr, 2013, 4: 463–473.
[6] Schurgers LJ, Teunissen KJF, Hamulyák K, et al. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7[J]. Blood, 2007, 109: 3279–3283.
[7] Marles RJ, Roe AL, Oketch-Rabah HA.US Pharmacopeial convention safety evaluation of menaquinone-7, a form of vitamin K[J]. Nutr Rev, 2017, 75: 553–578.
[8] Marchili MR, Santoro E, Marchesi A, et al. Vitamin K deficiency: a case report and review of current guidelines[J].Ital J Pediatr, 2018, 44: 1–5.
[9] Araki S, Shirahata A.Vitamin K deficiency bleeding in infancy[J]. Nutrients, 2020, 12: 780.
[10] Inaba N, Sato T, Yamashita T.Low-dose daily intake of vitamin K2 (menaquinone-7) improves osteocalcin γ-carboxylation: a double-blind, randomized controlled trials[J]. J Nutr Sci Vitaminol (Tokyo), 2015, 61: 471–480.
[11] 庄焕雄,陈东峰,徐孟凡,等. 维生素K2对绝经后骨质疏松症的防治作用及血清组织蛋白酶K影响[J].中国骨质疏松杂志, 2017, 23: 627–630.
[12] Knapen MHJ, Drummen NE, Smit E, et al. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women[J]. Osteo-poros Int, 2013, 24: 2499–2507.
[13] 胥小琴,张丹,陶新城,等. 维生素K2防治绝经后骨质疏松症作用的荟萃分析[J]. 中国骨质疏松杂志, 2021, 27: 1780–1787.
[14] 夏玉,殷光玲. 维生素K2防治骨质疏松症的研究进展[J]. 生物技术世界,2016(3):184–185.
[15] 周建烈,陈杰鹏,段丽丽,等. 维生素K2(MK-7)防治骨质疏松的作用机制研究进展[J]. 中国骨质疏松杂志, 2019, 25: 539–545.
[16] Geleijnse JM, Vermeer C, Grobbee DE, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study[J]. J Nutr, 2004, 134: 3100–3105.
[17] Vossen LM, Schurgers LJ, Van Varik BJ, et al. Menaquinone-7 supplementation to reduce vascular calcification in patients with coronary artery disease: rationale and study protocol (VitaK-CAC Trial)[J]. Nutrients, 2015, 7: 8905–8915.
[18] Hariri E, Kassis N, Iskandar JP, et al. Vitamin K2—a neglected player in cardiovascular health: a narrative review[J]. Open Heart, 2021, 8: e001715.
[19] 曹安澜,赖雨薇,陈亨贵,等. 维生素K与2型糖尿病关系的研究进展[J].中华预防医学杂志,2020,54:555–562.
[20] Zhong JH, Mo XS, Xiang BD, et al. Postoperative use of the chemopreventive vitamin K2 analog in patients with hepatocellular carcinoma[J]. PLoS One, 2013, 8: e58082.
[21] Popescu A, German M.Vitamin K2 holds promise for Alzheimer's prevention and treatment[J].Nutrients, 2021, 13: 2206.
[22] Mong MA.Vitamin K and the visual system—a narrative review[J]. Nutrients,2023,15:1948.
[23] Dofferhoff ASM, Piscaer I, Schurgers LJ, et al. Reduced vitamin K status as a potentially modifiable risk factor of severe coronavirus disease 2019[J]. Clin Infect Dis, 2021,73:e4039–e4046.
[24] Janssen R, Visser MPJ, Dofferhoff ASM, et al. Vitamin K metabolism as the potential missing link between lung damage and thromboembolism in Coronavirus disease 2019[J].Br J Nutr, 2021, 126: 191–198.
[25] De Brouwer B, Piscaer I, Von Der Thusen JH, et al. Should vitamin K be supplemented instead of antagonised in patients with idiopathic pulmonary fibrosis?[J]. Expert Rev Respir Med, 2018, 12: 169–175.
[26] Schwalfenberg GK.Vitamins K1 and K2: the emerging group of vitamins required for human health[J]. J Nutr Metab, 2017,2017: 6254836.
[27] Shearer MJ, Fu X, Booth SL.Vitamin K nutrition, metabolism, and requirements: current concepts and future research[J].Adv Nutr,2012,3: 182–195.
[28] Shearer M J, McBurney A, Barkhan P. Studies on the absorption and metabolism of phylloquinone (vitamin K1) in man[J]. Vitam Horm,1975,32: 513–542.
[29] Schurgers LJ, Vermeer C.Differential lipoprotein transport pathways of K-vitamins in healthy subjects[J]. Biochim Biophys Acta, 2002, 1570: 27–32.
[30] Sato T, Schurgers LJ, Uenishi K.Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women[J].Nutr J, 2012,11:93.
[31] Jones KS, Bluck LJC, Wang LY, et al. The effect of different meals on the absorption of stable isotope-labelled phylloquinone[J]. Br J Nutr, 2009, 102: 1195–1202.
[32] Turck D, Bresson J, Burlingame B, et al. Dietary reference values for vitamin K[J]. EFSA J, 2017, 15: e04780.
[33] Uematsu T, Nagashima S, Niwa M, et al. Effect of dietary fat content on oral bioavailability of menatetrenone in humans[J].J Pharm Sci, 1996, 85: 1012–1016.
[34] McDonald MG, Rieder MJ, Nakano M, et al. CYP4F2 is a vitamin K1 oxidase: an explanation for altered warfarin dose in carriers of the V433M variant[J]. Mol Pharmacol, 2009, 75: 1337–1346.
[35] Yan L, Zhou B, Nigdikar S, et al. Effect of apolipoprotein E genotype on vitamin K status in healthy older adults from China and the UK[J]. Br J Nutr, 2005, 94: 956–961.
[36] Newman P, Bonello F, Wierzbicki AS, et al. The uptake of lipoprotein‐borne phylloquinone (vitamin K1) by osteoblasts and osteoblast‐like cells: role of heparan sulfate proteoglycans and apolipoprotein E[J]. J Bone Miner Res, 2002, 17: 426–433.
[37] Macdonald HM, McGuigan FE, Lanham-New SA, et al. Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymerphisms[J]. Am J Clin Nutr, 2008, 87: 1513–1520.
[38] Crosier MD, Peter I, Booth SL, et al. Association of sequence variations in vitamin K epoxide reductase and γ-glutamyl carboxylase genes with biochemical measures of vitamin K status[J].J Nutr Sci Vitaminol (Tokyo), 2009, 55: 112–119.
[39] Shearer MJ, Newman P.Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis[J]. J Lipid Res, 2014,55: 345–362.
[40] Shearer MJ, Newman P.Metabolism and cell biology of vitamin K[J]. Thromb Haemost, 2008, 100: 530–547.
[41] Goncalves A, Margier M, Roi S, et al. Intestinal scavenger receptors are involved in vitamin K1 absorption[J].J Biol Chem, 2014, 289: 30743–30752.
[42] Takada T, Yamanashi Y, Konishi K, et al. NPC1L1 is a key regulator of intestinal vitamin K absorption and a modulator of warfarin therapy[J]. Sci Transl Med, 2015,7: 275ra23.
[43] Shearer M J, Okano T.Key pathways and regulators of vitamin K function and intermediary metabolism[J]. Annu Rev Nutr, 2018, 38: 127–151.
[44] 中川公恵. ビタミン K の生体内変換機構の消失により起こる疾患とその予防[J].薬学雑誌,2021,41:669-674.
[45] Okano T, Shimomura Y, Yamane M, et al. Conversion of phylloquinone (Vitamin K1) into menaquinone-4 (Vitamin K2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice[J]. J Biol Chem, 2008, 283: 11270–11279.
[46] Hirota Y, Tsugawa N, Nakagawa K, et al. Menadione (vitamin K3) is a catabolic product of oral phyllo-quinone (vitamin K1) in the intestine and a circulating precursor of tissue menaquinone–4 (vitamin K2) in rats[J]. J Biol Chem, 2013, 288: 33071–33080.
[47] Novotny JA, Kurilich AC, Britz SJ, et al. Vitamin K absorption and kinetics in human subjects after consumption of 13C–labelled phylloquinone from kale[J]. Br J Nutr, 2010, 104: 858–862.
[48] Thijssen HHW.Vitamin K status in human tissues: tissue-specific accumulation of phylloquinone and menaquinone–4[J]. Br J Nutr, 1996, 75: 121–127.
[49] Thijssen HHW, Drittij-Reijnders MJ.Vitamin K distribution in rat tissues: dietary phylloquinone is a source of tissue menaquinone–4[J]. Br J Nutr, 1994, 72: 415–425.
[50] Usui Y, Tanimura H, Nishimura N, et al. Vitamin K concentrations in the plasma and liver of surgical patients[J]. Am J Clin Nutr, 1990, 51: 846–852.
[51] Card D J, Gorska R, Cutler J, et al. Vitamin K metabolism: current knowledge and future research[J]. Mol Nutr Food Res,2014,58: 1590–1600.
[52] Thijssen HHW, Vervoort LMT, Schurgers LJ, et al. Menadione is a metabolite of oral vitamin K[J]. Br J Nutr, 2006, 95: 260–266.
